Diabetic Foot Ulcer

Centaur Pharmaceuticals launches for the first time in the world – a New Chemical Entity (NCE)–’WOXHeal®’ in the treatment of Diabetic Foot Ulcer

●        25% people with Diabetes develop a Diabetic Foot Ulcer  ●        1 in 5 people developing severe infection undergo foot amputation ●        Developed…

4 years ago

Stempeutics out licenses its novel stem cell product “Stempeucel-DFU” to Cipla for treating non healing Diabetic Foot Ulcer (DFU)

Diabetic foot is one of the most significant and devastating complications of diabetes Out of approx. 70 million diabetics in India,…

5 years ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420